Previous 10 | Next 10 |
OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it has received clearance from the FDA to amend the pediatric age limita...
OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it has entered into an extensive research collaboration with Public Hea...
Oxford Immunotec Global PLC (OXFD) Q1 2021 Earnings Conference Call August 04, 2020 08:00 AM ET Company Participants Matt McLaughlin - Chief Financial Officer Peter Wrighton-Smith - Chief Executive Officer Conference Call Participants Sung Ji Nam - BTIG Chris Lin - Cowen ...
Image source: The Motley Fool. Oxford Immunotec Global PLC (NASDAQ: OXFD) Q2 2020 Earnings Call Aug 4, 2020 , 8:00 a.m. ET Operator Continue reading
The following slide deck was published by Oxford Immunotec Global PLC in conjunction with their 2020 Q2 earnings Read more ...
Oxford Immunotec Global (NASDAQ: OXFD ) : Q2 GAAP EPS of -$0.37 misses by $0.07 . More news on: Oxford Immunotec Global PLC, Earnings news and commentary, Healthcare stocks news, Read more ...
Second quarter revenue of $5.8 million, a decrease of 70% compared to prior year period, due to the impact of COVID-19 Ended the quarter with approximately $165 million of cash and cash equivalents Third quarter revenue estimated to be between $18 - $19 million OXFORD, United ...
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 21, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2020 financial results before the open of the market...
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), today announced that it has entered into a long-term agreement to supply its T-SPOT. TB test and associated accessories to the Stop TB Partnership - Glob...
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 19, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces the release of the T-SPOT Discovery SARS-CoV-2 test kit. This kit is for resear...
News, Short Squeeze, Breakout and More Instantly...
Oxford Immunotec Global PLC Company Name:
OXFD Stock Symbol:
NASDAQ Market:
Oxford Immunotec Global PLC Website:
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection Canada NewsWire OXFORD , United Kingdom and MARLBOROUGH, Ma...
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announces it has worked with GC MS and MESDIA Co., Ltd. to enter into an MOU to market t...
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces an update to the configuration of the T-SPOT Discovery SARS-CoV-2 kit. Th...